Webinars and Commercial Conversations — Register Now
Tuesday, November 10, 2026, 1:00 PM-2 PM ET
Join us for a session to help improve diagnostic accuracy in your practice when scoring HER2 IHC 0 with faint, incomplete membrane staining in ≤10% of tumor cells vs IHC 0 with no membrane staining detected in patients with mBC.
Webinar presenter Samuel Caughron, MD, FCAP, Chief Strategy Officer, MAWD Pathology, Medical Director of Laboratory, AdventHealth Kansas City, Medical Director of Laboratory, Labcorp, President, Member & Director, Pathology Ventures, LLC
CAP TODAY does not endorse any of the products or services named within. This program is intended for US healthcare professionals. This program is being sponsored by AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Monday, November 16, 2026, 12:30 PM-2 PM ET
Hear experts discuss a multidisciplinary approach to oncopathology for HER2
assessments for solid tumors in the absence of a companion diagnostic.
Webinar presenters Funda Meric-Bernstam, MD, Chair, Department of Investigational Cancer Therapeutics Medical Director, Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, and Emina E. Torlakovic, MD, PhD, College of Medicine, University of Saskatchewan, Canadian Biomarker Quality Assurance, Saskatoon, Saskatchewan, Canada, and Carol Cheung, MD, PhD, JD, FRCPC, Deputy Director, Canadian Biomarker Quality, Assurance—Programme canadien d’assurance de la qualité des biomarqueurs
CAP TODAY does not endorse any of the products or services named within. This program is being sponsored by Daiichi Sankyo, Inc. and AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, November 18, 2026, 12:00 PM-1 PM ET
Join leading pathology experts, Savitri Krishnamurthy, MD, and Marilyn Bui, MD, PhD, for a webinar exploring potential challenges in HER2 IHC testing for breast cancer, emerging evidence supporting digital and computational pathology as assistive tools for pathologists in HER2 IHC assessment, and practical considerations for real-world implementation and adoption.
Webinar presenters Savitri Krishnamurthy, MD, Professor of Pathology, Department of Anatomical Pathology The University of Texas MD Anderson Cancer Center, Houston, Texas, and Marilyn Bui, MD, PhD, Surgical Pathologist and Cytopathologist Member and Professor, Departments of Pathology, Machine Learning, and Translational Pathology, Scientific Director, Analytic Microscopy Core Chair, Women in Oncology Executive Board Moffitt Cancer Center, Tampa, Florida
CAP TODAY does not endorse any of the products or services named within. This program is being sponsored by Daiichi Sankyo, Inc. and AstraZeneca. The speakers are being compensated for their presentations. The program is not CME accredited and may not be used for CME credit.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, December 9, 2026, 12 PM-1 PM ET
Hear an expert pathologist discuss the role of HER2 IHC testing and scoring in solid tumors including endometrial, ovarian, cervical, bladder, non-small cell lung, colorectal, and biliary cancers
Webinar presenter Michelle Shiller, DO, MSPT, Baylor Sammons Cancer Center; Fulgent Genetics; Texas Cancer Interception Institute
CAP TODAY does not endorse any of the products or services named within. This program is intended for US healthcare professionals. This program is being sponsored by AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
Product Spotlight
ARKRAY
| Company | ARKRAY |
|---|---|
| Name of urinalysis instrument | AUTION Eleven AE-40222 |
| Contact | Mariann Amador |
| City, State | Minneapolis, MN |
| Phone | 855-646-3108 |
| Website | |
| Type of instrument | urine chemistry |
| Instrument list price | — (available via purchase) |
| First year instrument sold in the U.S. | 2017 |
| Approximate No. of units in clinical use in the U.S./outside the U.S. | 700/7,200 (worldwide) |
| Foreign countries where company markets instrument | worldwide |
| Country where instrument is designed/manufactured | Japan/Japan |
| Human languages (other than English) supported | — |
| Intended urine sample volume per day | — |
| Dimensions (H×W×D) | 6.5 × 8.3 × 12.9 in. |
| Weight fully loaded with reagents/without reagents | —/7.9 lbs.†† |
| Power requirements | 100–240 VAC (50–60 Hz) |
| Mean time between failure of instrument | 600 days |
| Events that cause instrument to lock or stop analysis | user ID failure, result error |
| • Urine chemistry tests available on instrument in the U.S. | bilirubin (0.5–14.0 mg/dL), hemoglobin (0.03–1.0 mg/dL), glucose (30–1,000 mg/dL), ketone (5–150 mg/dL), leukocyte esterase (25–500 leukocytes/µL), nitrite (0.08–0.5 mg/dL), pH (5–9), protein (10–1,000 mg/dL), specific gravity (1.005–1.030), urobilinogen (2–16 mg/dL) |
| • Color compensation pad included/Flagging thresholds customizable | yes/— |
| • Test strip configuration | loosely packed in bottles |
| • Calibration required after each test strip lot No. change | no |
| • Frequency of customer-performed calibration/Form of calibration | — |
| • How results are displayed for urine chemistry | semiquantitative |
| • Specific gravity correction for protein/glucose | no/no |
| • Microscopy/sediment technology | — |
| • Microscopy/sediment analysis parameters | — |
| • Flagging thresholds customizable | — |
| • Instrument eliminates amorphous crystal interference before sample analysis | — |
| • How results are displayed for microscopy/sediment | — |
| • Reporting format customizable | — |
| • No. of results that can be held in internal memory | — |
| Reagent shelf life/storage temp. for unopened containers of calibrator | — |
| Reagent shelf life/storage temp. for opened containers of calibrator | — |
| Reagent shelf life/storage temp. for unopened containers of control reagent | 547 days/2–8°C |
| Reagent shelf life/storage temp. for opened containers of control reagent | 31 days/2–8°C |
| Reagent barcode-reading capability | yes, for all tests (can read Codabar [NW-7], Code 39, Code 128, PDF 417, ITF) |
| How often quality control samples are run | daily |
| Sample throughput per hour/Time to first result for chemistry | 514/1 min. |
| Sample throughput per hour/Time to first result for microscopy/sediment | — |
| Analyzer has stat mode | no |
| FDA approved for body fluid analysis | no |
| Sample dilutions required for urinalysis/body fluid analysis | no/not applicable |
| Minimum width of sample tube/Minimum length of sample tube | — |
| Conditions or substances that prevent a sample from being run | blood, visible turbidity |
| Means of sample ID entry | barcode scan, manual entry |
| Built-in liquid-level sensing for samples | no |
| Information that can be barcode scanned on instrument | operator identifier, specimen identifier, reagent lot No. |
| Compatible with laboratory automation systems | no |
| How LOINC codes for results are made available | e-mail query |
| Software includes reflex testing/cross-check functionality | — |
| Instrument automatically generates consolidated report* | — |
| Instrument archives patient data | no |
| Instrument connections to transfer information | directly to LIS or via commercial middleware (Data Innovations) |
| Interface standards or formats supported | ASTM 1394-91, ASTM 1381 |
| Bidirectional interface | no |
| Test results can be transmitted to LIS as soon as tests completed | yes |
| Connection to LIS/EHR to upload patient and QC results | LIS: direct serial, hospital network/EHR: option not available |
| Information included in transmission to data-management system | patient ID, specimen ID, result |
| Training included with instrument purchase | no |
| Approximate scheduled maintenance time required | 5 min. daily |
| Onboard diagnostics for troubleshooting | no |
| Provide list of client sites to potential customers on request | no (information is confidential) |
| Clients restricted from sharing their experience with company or software | no |
| Distinguishing instrument features (supplied by company) | proven reliability with less than one unscheduled service event per year; small semiautomated footprint |
| *chemistry and microscopy results in one report; Note: a dash in lieu of an answer means company did not answer; question or question is not applicable | †also sold via distribution partners; ††reagents not kept onboard |